Liberum appointed Joint Corporate Broker to MedicX Fund Limited

Liberum is pleased to announce its appointment as Joint Corporate Broker to MedicX Fund Limited.

MedicX is a specialist primary healthcare REIT which invests in modern, purpose-built primary healthcare properties in the UK & Republic of Ireland. The Company has a portfolio of 151 completed properties with an average value of £4.4m.

MedicX selectively buys high quality dominant assets or forward-funds new schemes under framework agreements with a range of experienced developers in both the UK and the Republic of Ireland.

The fund is listed on the Premium Segment of the Main Market and has a market capitalisation of c.£346m.

Liberum has been appointed as Joint Corporate Broker alongside Canaccord, with immediate effect.

Liberum Team

Board – David Parsons
Investment Banking – Richard Crawley, Jamie Richards, Laura Hamilton, William Hall

Sales – John Mozley
Research – David Brockton 
Corporate Access – Lucy Williams

Press Enquiries: Redleaf Polhill

Call: +44 (0)20 7382 4747

Follow Liberum


New York


Ropemaker Place, Level 12 25 Ropemaker Street London EC2Y 9LY

New York

20th Floor 575 Fifth Avenue New York NY 10017